drugset / Trial / NCT06070701
NOL-Guided Superficial Parasternal Intercostal Plane Block Versus Erector Spinae Plane Block
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial focuses on an elaborate, propensity-matched, non-inferiority comparison of NOL-guided Superficial Parasternal Intercostal Plane Block (SPIPB) and Erector Spinae Plane Block (ESPB) within the context of open-heart surgery with cardiopulmonary bypass.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-03-01
- Completion
- 2024-04-01
Publications
- Results Balan C, Tomescu DR, Valeanu L, Morosanu B, Stanculea I, Coman A, Stoian A, Bubenek-Turconi SI. Nociception Level Index-Directed Erector Spinae Plane Block in Open Heart Surgery: A Randomized Controlled Clinical Trial. Medicina (Kaunas). 2022 Oct 16;58(10):1462. doi: 10.3390/medicina58101462.
- Results Balan C, Tomescu DR, Bubenek-Turconi SI. Nociception Control of Bilateral Single-Shot Erector Spinae Plane Block Compared to No Block in Open Heart Surgery-A Post Hoc Analysis of the NESP Randomized Controlled Clinical Trial. Medicina (Kaunas). 2023 Jan 30;59(2):265. doi: 10.3390/medicina59020265.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Fentanyl | Other / unclassified | 1.5 ug/kg | — |
| Background | Fentanyl | Other / unclassified | 5 ug/kg | — |
| Background | Morphine | Other / unclassified | 0.03 mg/kg | — |